Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

echo therapeutics pty ltd - peginterferon alfa-2a, quantity: 135 microgram - injection, solution - excipient ingredients: water for injections; sodium acetate; acetic acid; polysorbate 80; sodium chloride; benzyl alcohol - chronic hepatitis c (chc): the combination of pegasys and copegus is indicated for the treatment of chronic heptitis c in patients who have received no prior interferon therapy (treatment naive patients) and patients who have failed previous treatment with interferon alfa (pegylated or non-pegylated) alone or in combination therapy with ribavirin. the combination of pegasys and copegus is also indicated for the treatment of chronic hepatitis c in patients with clinically stable human immunodeficiency virus (hiv) co-infection who have previously not received interferon therapy. pegasys monotherapy is indicated for the for the treatment of chronic heptitis c in treatment naive patients (see dosage and administration; chronic hepatitis c: treatment naive patients). patients must be 18 years of age or older and have compensated liver disease. chronic hepatitis b (chb): pegasys is indicated for the treatment of chronic heptitis b in adult patients with evidence of viral replication and liver inflammation and compensated liver disease.

Izraēla - angļu - Ministry of Health

truemed ltd, israel - migalastat as hydrochloride - hard capsule - migalastat as hydrochloride 123 mg - galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of fabry disease (α-galactosidase a deficiency) and who have an amenable mutation.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

echo therapeutics pty ltd - mitomycin, quantity: 20 mg - injection, powder for - excipient ingredients: nitrogen; mannitol; hydrochloric acid; sodium hydroxide - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,betacarotene,biotin,calcium folinate,calcium glycinate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,d-alpha-tocopheryl acid succinate,iron (ii) glycinate,levomefolate glucosamine,magnesium glycinate,manganese (ii) glycinate,mecobalamin (co-methylcobalamin),menaquinone 7,nicotinamide,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,riboflavin,riboflavin sodium phosphate,selenomethionine,thiamine hydrochloride,zinc glycinate -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,betacarotene,biotin,calcium folinate,calcium glycinate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,d-alpha-tocopheryl acid succinate,iron (ii) glycinate,levomefolate glucosamine,magnesium glycinate,manganese (ii) glycinate,mecobalamin (co-methylcobalamin),menaquinone 7,nicotinamide,potassium iodide,pyridoxal 5-phosphate monohydrate,pyridoxine hydrochloride,riboflavin,riboflavin sodium phosphate,selenomethionine,thiamine hydrochloride,zinc glycinate -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 62466 - soft-tissue surgical forceps, tweezers-like, reusable - reusable forceps intended to assist in the grasping, clamping, and/or suturing of soft tissues during surgical procedures.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 60341 - surgical diode laser system - the neov laser is intended to be used for treatments requiring the heating of tissue andor/or blood up to coagulation or vaporisation.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 34917 - catheter, urological, foley - the urethral catheterisation device (ucd) is intended for use for bladder management including urine drainage, collection and measurement and/or bladder fluid instillation or irrigation.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 58865 - vascular introducer kit - the introducer set allows the smooth introduction of a catheter or probe into a peripheral vein. the introducer set must not be inserted into the central nervous system or into the central circulatory system.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 58204 - electroporation therapy system - the cutis is intended to be connected to the epore generator for the delivery of electroporation pulses directly to the targeted area using a series of needles.